Replies to post #12956 on Sorrento Therapeutics Inc (SRNE)

[1776club]

ZTlido revenue is an unknown since SCILEX was approved for Insurance Coverage for ~100 million people through pharmacy benefit managers (PBMs) and health plans on Jan. 14, 2019. That is three years ago so I guess we see how word of mouth is going since I do not see or hear any advertising for it.
Found this interesting:
https://files.nc.gov/ncshp/documents/files/Lidoderm-ZTLido-Policy-125-C-09-2019a.pdf

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1b17507-4560-490d-a388-74e7fd7eaa5e